Clinical Scorecard: Induction of Sympathetic Ophthalmia Following Vitrectomy for Endogenous Fungal Endophthalmitis: A Case Study and Review of Existing Literature
At a Glance
Category
Detail
Condition
Sympathetic Ophthalmia
Key Mechanisms
Cell-mediated immune response against ocular antigens exposed during trauma or surgery.
Target Population
Patients with a history of ocular trauma or intraocular surgery.
Care Setting
Ophthalmology clinics and hospitals.
Key Highlights
Sympathetic ophthalmia can occur after vitrectomy for fungal endophthalmitis.
The case involved a 22-year-old man with a history of Aspergillus flavus infection.
Diagnosis was supported by multimodal imaging techniques.
Treatment included prednisone and adalimumab, stabilizing the patient's condition.
Long-term follow-up showed no recurrences.
Guideline-Based Recommendations
Diagnosis
Utilize multimodal imaging including OCT, ICGA, and fundus examination for diagnosis.
Management
Administer corticosteroids and immunosuppressive therapy for treatment.
Monitoring & Follow-up
Regular follow-up to assess visual acuity and monitor for recurrences.
Risks
Potential for vision loss due to the inflammatory process.
Patient & Prescribing Data
Individuals with sympathetic ophthalmia following ocular surgery.
Combination therapy with corticosteroids and immunomodulators may be effective.
Clinical Best Practices
Early diagnosis and intervention are crucial for managing sympathetic ophthalmia.
Consider the possibility of sympathetic ophthalmia in patients with a history of ocular surgery and unexplained visual changes.
Nimesh A. Patel, MD, demonstrates management of a dislocated Akreos AO60 intraocular lens (IOL; Bausch + Lomb) that had been previously fixated with Prolene sutures, and a panel of experienced vitreoretinal surgeons discusses secondary IOL fixation, lens repositioning, suture management, and long-term considerations in complex aphakia cases.
